BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P100
Near historical high
vs 2Y Ago
17.7x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
2025716.08%
202445.39%
202340.37%
2022-12.91%
2021-4.95%
2020-53.16%
20193.23%
2018-124.09%
201729.37%
2016-221.94%